Mesenchymal stromal cells in transplantation rejection and tolerance.

Mesenchymal stromal cells (MSCs) have recently emerged as promising candidates for cell-based immunotherapy in solid organ transplantation (SOT). In addition to immune modulation, MSCs possess proreparative properties and preclinical studies indicate that MSCs have the capacity to prolong graft surv...

Full description

Bibliographic Details
Main Authors: English, K, Wood, K
Format: Journal article
Language:English
Published: 2013
_version_ 1797077015053991936
author English, K
Wood, K
author_facet English, K
Wood, K
author_sort English, K
collection OXFORD
description Mesenchymal stromal cells (MSCs) have recently emerged as promising candidates for cell-based immunotherapy in solid organ transplantation (SOT). In addition to immune modulation, MSCs possess proreparative properties and preclinical studies indicate that MSCs have the capacity to prolong graft survival and in some cases induce tolerance. Currently, the application of MSCs in SOT is being evaluated in phase I/II clinical trials. Whereas the mechanisms of action used by MSC immunomodulation have been somewhat elucidated in vitro, the data from preclinical transplant models have been unclear. Furthermore, the optimal timing, dose, and route of administration remain to be elucidated. Importantly, MSCs have the ability to sense their environment, which may influence their function. In this article, we discuss the impact of the local microenvironment on MSCs and the mechanisms of MSC immunomodulation in the setting of SOT.
first_indexed 2024-03-07T00:11:43Z
format Journal article
id oxford-uuid:79760fa1-5feb-49f7-9082-def168ed8fb7
institution University of Oxford
language English
last_indexed 2024-03-07T00:11:43Z
publishDate 2013
record_format dspace
spelling oxford-uuid:79760fa1-5feb-49f7-9082-def168ed8fb72022-03-26T20:37:35ZMesenchymal stromal cells in transplantation rejection and tolerance.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:79760fa1-5feb-49f7-9082-def168ed8fb7EnglishSymplectic Elements at Oxford2013English, KWood, KMesenchymal stromal cells (MSCs) have recently emerged as promising candidates for cell-based immunotherapy in solid organ transplantation (SOT). In addition to immune modulation, MSCs possess proreparative properties and preclinical studies indicate that MSCs have the capacity to prolong graft survival and in some cases induce tolerance. Currently, the application of MSCs in SOT is being evaluated in phase I/II clinical trials. Whereas the mechanisms of action used by MSC immunomodulation have been somewhat elucidated in vitro, the data from preclinical transplant models have been unclear. Furthermore, the optimal timing, dose, and route of administration remain to be elucidated. Importantly, MSCs have the ability to sense their environment, which may influence their function. In this article, we discuss the impact of the local microenvironment on MSCs and the mechanisms of MSC immunomodulation in the setting of SOT.
spellingShingle English, K
Wood, K
Mesenchymal stromal cells in transplantation rejection and tolerance.
title Mesenchymal stromal cells in transplantation rejection and tolerance.
title_full Mesenchymal stromal cells in transplantation rejection and tolerance.
title_fullStr Mesenchymal stromal cells in transplantation rejection and tolerance.
title_full_unstemmed Mesenchymal stromal cells in transplantation rejection and tolerance.
title_short Mesenchymal stromal cells in transplantation rejection and tolerance.
title_sort mesenchymal stromal cells in transplantation rejection and tolerance
work_keys_str_mv AT englishk mesenchymalstromalcellsintransplantationrejectionandtolerance
AT woodk mesenchymalstromalcellsintransplantationrejectionandtolerance